Variant report
Variant | nsv966100 |
---|---|
Chromosome Location | chr22:30530653-30547684 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:30543067-30543100 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr22:30545465-30545819 | HCT-116 | colon: | n/a | n/a |
3 | CEBPB | chr22:30540308-30540629 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr22:30541131-30541314 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr22:30537038-30537044 | Fibrobl | skin: | n/a | n/a |
6 | CTCF | chr22:30537045-30537055 | Fibrobl | skin: | n/a | n/a |
7 | CTCF | chr22:30537005-30537033 | Fibrobl | skin: | n/a | n/a |
8 | ELK1 | chr22:30532231-30532240 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr22:30546435-30546440 | GM12878 | blood: | n/a | n/a |
10 | ESR1 | chr22:30532447-30532782 | ECC-1 | luminal epithelium: | n/a | n/a |
11 | GATA3 | chr22:30532013-30532079 | SH-SY5Y | brain: | n/a | n/a |
12 | JUND | chr22:30546117-30546149 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | KAP1 | chr22:30542935-30543206 | K562 | blood: | n/a | n/a |
14 | KAP1 | chr22:30539281-30539665 | U2OS | brain: | n/a | n/a |
15 | KAP1 | chr22:30539258-30539717 | HEK293 | kidney: | n/a | n/a |
16 | MAFF | chr22:30536496-30536750 | HepG2 | liver: | n/a | chr22:30536601-30536619 |
17 | MAFK | chr22:30536486-30536768 | IMR90 | lung: | n/a | chr22:30536602-30536617 |
18 | MAFK | chr22:30536428-30536763 | HepG2 | liver: | n/a | chr22:30536602-30536617 |
19 | MAFK | chr22:30536530-30536746 | HepG2 | liver: | n/a | chr22:30536602-30536617 |
20 | SETDB1 | chr22:30538883-30539916 | U2OS | brain: | n/a | n/a |
21 | SETDB1 | chr22:30545389-30546055 | U2OS | brain: | n/a | n/a |
22 | STAT3 | chr22:30532091-30532201 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | STAT3 | chr22:30532167-30532234 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | STAT3 | chr22:30531741-30531941 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | TAL1 | chr22:30540412-30540776 | K562 | blood: | n/a | n/a |
26 | WRNIP1 | chr22:30540630-30540641 | GM12878 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225971 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546390274 | chr22:30533654-30533655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535757221 | chr22:30533730-30533731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs117676187 | chr22:30533752-30533753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569170737 | chr22:30533764-30533765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117065079 | chr22:30533775-30533776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557921901 | chr22:30533777-30533778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572870156 | chr22:30533818-30533819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77394949 | chr22:30533826-30533827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs56157019 | chr22:30533832-30533833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555073984 | chr22:30533848-30533849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573340085 | chr22:30533853-30533854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192115030 | chr22:30533855-30533856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5763801 | chr22:30533929-30533930 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs563664533 | chr22:30534032-30534033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142663191 | chr22:30534080-30534081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546095558 | chr22:30534088-30534089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145746957 | chr22:30534139-30534140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13056990 | chr22:30534161-30534162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs537466167 | chr22:30534190-30534191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374725442 | chr22:30535407-30535408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182473749 | chr22:30535498-30535499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553529357 | chr22:30535530-30535531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73164728 | chr22:30535569-30535570 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs538704456 | chr22:30535576-30535577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372299043 | chr22:30535647-30535648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141731823 | chr22:30535673-30535674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566649256 | chr22:30535697-30535698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186905614 | chr22:30535732-30535733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548748640 | chr22:30535783-30535784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567034870 | chr22:30535861-30535862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537519290 | chr22:30535867-30535868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555742331 | chr22:30535918-30535919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs118131178 | chr22:30535937-30535938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192739151 | chr22:30535939-30535940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs36099958 | chr22:30535944-30535945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs66977637 | chr22:30535945-30535946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113842019 | chr22:30535951-30535952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs386395189 | chr22:30535952-30535953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs60030763 | chr22:30535963-30535964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574857964 | chr22:30535964-30535965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573438840 | chr22:30535986-30535987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9608847 | chr22:30536056-30536057 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs562230164 | chr22:30536083-30536084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9614148 | chr22:30536091-30536092 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs184284228 | chr22:30536099-30536100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562882112 | chr22:30536103-30536104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533407576 | chr22:30536144-30536145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551462107 | chr22:30536182-30536183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565455717 | chr22:30536232-30536233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113704691 | chr22:30536266-30536267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 17322880 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurofibromatosis type 2 | 19566914 | CNVD |
Autism | 19384346 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Myelofibrosis | 22110671 | CNVD |
muscular dystrophy type 1D | 21248746 | CNVD |
Leukoplakia | 24403051 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:30533600-30534200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr22:30535400-30539600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr22:30539600-30540000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr22:30540200-30541000 | Enhancers | K562 | blood |
5 | chr22:30540800-30541000 | Enhancers | Osteobl | bone |
6 | chr22:30540800-30541600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr22:30541000-30555200 | Weak transcription | Osteobl | bone |
8 | chr22:30545400-30550200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr22:30546000-30547400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr22:30546000-30550000 | Enhancers | Primary B cells from cord blood | blood |
11 | chr22:30546200-30547200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr22:30546400-30546800 | Enhancers | Fetal Thymus | thymus |
13 | chr22:30546400-30547000 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr22:30546400-30547000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr22:30546400-30547200 | Enhancers | Primary hematopoietic stem cells | blood |
16 | chr22:30546400-30547200 | Enhancers | Thymus | Thymus |
17 | chr22:30547000-30548000 | Weak transcription | Primary B cells from peripheral blood | blood |
18 | chr22:30547000-30550000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
19 | chr22:30547200-30555400 | Weak transcription | Primary hematopoietic stem cells | blood |
20 | chr22:30547200-30555600 | Weak transcription | Thymus | Thymus |